LONDON, Oct. 14, 2014 /PRNewswire/ -- Synthetic biology is an emerging biotechnology discipline with a wide range of applications. This BCC Research report determines the specific applications and forecast global market demand for synthetic biology products through 2018. This analysis provides a quantitative basis and market context for companies to make strategic choices about participation in the synthetic biology industry.Synthetic biology technologies, growth driving forces, market applications, industry structure and competitive dynamics, companies and industry alliances, future market potential, and product sales forecasts for the period 2013 through 2018 are also analyzed.
Use this report to:- Receive a comprehensive analysis of the emerging synthetic biology industry.- Receive information on the forces driving synthetic biology market growth.- Receive an analysis of the synthetic biology industry's structure, competition, and intellectual property landscape.- Receive information on companies and industry alliances, and key segments of the industry.
Highlights- The global synthetic biology market reached nearly $2.1 billion in 2012 and $2.7 billion in 2013. This market is expected to grow to $11.8 billion in 2018 with a compound annual growth rate (CAGR) of 34.4% over the five-year period from 2013 to 2018.- Enabled products, as a segment, reached $2.0 billion in 2013. The segment is projected to grow to nearly $9.8 billion in 2018, a CAGR of 36.7% over the five-year period from 2013 to 2018.- Core products, as a segment, reached $349.8 million in 2013. The segment is projected to grow to nearly $1.1 billion in 2018, a CAGR of 25.4% over the five-year period from 2013 to 2018.
INTRODUCTIONSTUDY GOALS AND OBJECTIVESBCC Research's goal for this study is to determine the specific applications and forecast global market demand for synthetic biology products over a five–year periodfrom 2013 through 2018. Our particular interest is to characterize and quantify the synthetic biology product market potential by product type and end use marketsegments. We also analyze the synthetic biology industry structure, competitors and intellectual property landscape. Synthetic biology markets reviewed in this report include Enabling Products, Biologic Components, Integrated Systems and Enabled Products.Our key objective is to present a comprehensive analysis of the emerging synthetic biology industry, with an emphasis on products and technologies that are commerciallyimportant in the 2013 through 2018 time period. Market segments with rapid growth rates are highlighted, as well as those segments with large market potential. Thisanalysis provides a quantitative basis and market context for companies to make strategic choices about participation in the synthetic biology industry. The study will be particularly useful to companies supplying synthetic genes and DNA, oligonucleotides, DNA sequencing instruments, bioinformatics, cell culture media,biofuels, specialty chemicals, pharmaceuticals, vaccines, diagnostics, agricultural seeds, pest control systems, microfluidics, and life sciences tools.
REASONS FOR DOING THE STUDYSynthetic biology is an emerging biotechnology discipline with a wide range of applications. While there is enormous potential for future applications, syntheticbiology has a significant number of near–term commercial opportunities, and the list of new products and applications is continuously growing. Applications include specialtychemicals, enzymes, synthetic genes and other DNA parts as well as pharmaceuticals, diagnostics, agricultural seeds, vaccines, biofuels, and chassis microorganisms.It is important for companies in industries impacted by synthetic biology to sort through the many potential applications; to identify near–term commercialopportunities for product development and competitive strategy. This report provides pertinent information to assist companies in prioritizing product opportunities, andestablishing a solid framework for strategic planning.Synthetic biology encompasses a range of industries including life science tools, biotechnology, pharmaceuticals, diagnostics, energy, and chemicals. Because of itswide scope, synthetic biology plays an important role in the future industrial economy. Continuing advances in enabling technologies such as DNA synthesis and sequencing,specialty media, and bioinformatics, as well as a need for renewable feedstocks, are driving the growth of the synthetic biology market. Developments in thesemultidisciplinary fields promise to advance the synthetic biology industry and create unique market opportunities. This report analyzes these trends and their impact on thefuture markets for synthetic biology products. Based on these market and technology dynamics, it is especially timely to examine the current and future synthetic biology markets.
CONTRIBUTION OF THE STUDY AND FOR WHOMWe have compiled a study of existing and future synthetic biology products and technologies that will be commercially important in the main end–user segments of lifescience research, pharmaceuticals, diagnostics, energy, chemicals, and agriculture. We present markets by end–user segment (R&D, diagnostics and pharmaceuticals,energy, chemicals, and agriculture) and by product type (enabling products, biologic components, integrated systems, and enabled products). Key market segments arecovered, including synthetic genes, agriculture, biofuels, specialty chemicals, and pharmaceuticals. We analyze synthetic biology technologies, growth driving forces, market applications, industry structure and competitive dynamics, companies and industry alliances, future market potential, and product sales forecasts for the period 2013 through 2018. We project the future use of synthetic biology products in the main end–user segments and by product type.This report will be of particular interest to companies in the industries of pharmaceuticals, chemicals, enzymes, energy, agriculture, diagnostics, bioinformatics, biotechnology, and nanobiotechnology, as well as suppliers of genomics tools, DNA synthesis and DNA sequencing products. It will also be of high interest to professionalswithin governments and regulatory agencies to understand the scope and pace of synthetic biology technologies as they reach the market.
SCOPE AND FORMATThe study scope includes core synthetic biology products (synthetic genes, other DNA parts, chassis organisms, synthetic cells), enabling technologies (DNA sequencing,oligonucleotides, specialty media, bioinformatics), and enabled technologies (biofuels, specialty chemicals, diagnostics, pharmaceuticals, agriculture) that are alreadycommercialized or are forecast to be commercialized within the next five years. We analyze key synthetic biology technologies and products to determine present andfuture market status, and forecasted growth from 2013 through 2018. We also discuss strategic alliances, industry structures, competitive dynamics, patents, and marketdriving forces.BCC Research examines the synthetic biology industry by market segment, including suppliers of synthetic genes, enzymes, pharmaceuticals, biofuels, and specialtychemicals. The role of key strategic alliances from 2012 through 2014 is discussed. Emerging markets including synthetic genes, synthetic biology–enabled drugs andvaccines, chassis organisms, as well as metabolically–engineered factories for producing synthetic fuels and specialty chemicals are analyzed and more than 130companies in these fields are highlighted.
METHODOLOGYBCC Research surveys key users and producers in each of the end–user market segments and technology fields that will be commercially important during the nextfive years. Discussions with industry thought leaders, as well as secondary market research was performed. Based on our analysis, we project the future applications of synthetic biology technologies in the major end–user market segments and by technology type, and forecast sales revenues for 2013 through 2018.
Download the full report: https://www.reportbuyer.com/product/2212006/
About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.com
For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
SOURCE ReportBuyer
Advertisement
Use this report to:- Receive a comprehensive analysis of the emerging synthetic biology industry.- Receive information on the forces driving synthetic biology market growth.- Receive an analysis of the synthetic biology industry's structure, competition, and intellectual property landscape.- Receive information on companies and industry alliances, and key segments of the industry.
Advertisement
Highlights- The global synthetic biology market reached nearly $2.1 billion in 2012 and $2.7 billion in 2013. This market is expected to grow to $11.8 billion in 2018 with a compound annual growth rate (CAGR) of 34.4% over the five-year period from 2013 to 2018.- Enabled products, as a segment, reached $2.0 billion in 2013. The segment is projected to grow to nearly $9.8 billion in 2018, a CAGR of 36.7% over the five-year period from 2013 to 2018.- Core products, as a segment, reached $349.8 million in 2013. The segment is projected to grow to nearly $1.1 billion in 2018, a CAGR of 25.4% over the five-year period from 2013 to 2018.
INTRODUCTIONSTUDY GOALS AND OBJECTIVESBCC Research's goal for this study is to determine the specific applications and forecast global market demand for synthetic biology products over a five–year periodfrom 2013 through 2018. Our particular interest is to characterize and quantify the synthetic biology product market potential by product type and end use marketsegments. We also analyze the synthetic biology industry structure, competitors and intellectual property landscape. Synthetic biology markets reviewed in this report include Enabling Products, Biologic Components, Integrated Systems and Enabled Products.Our key objective is to present a comprehensive analysis of the emerging synthetic biology industry, with an emphasis on products and technologies that are commerciallyimportant in the 2013 through 2018 time period. Market segments with rapid growth rates are highlighted, as well as those segments with large market potential. Thisanalysis provides a quantitative basis and market context for companies to make strategic choices about participation in the synthetic biology industry. The study will be particularly useful to companies supplying synthetic genes and DNA, oligonucleotides, DNA sequencing instruments, bioinformatics, cell culture media,biofuels, specialty chemicals, pharmaceuticals, vaccines, diagnostics, agricultural seeds, pest control systems, microfluidics, and life sciences tools.
REASONS FOR DOING THE STUDYSynthetic biology is an emerging biotechnology discipline with a wide range of applications. While there is enormous potential for future applications, syntheticbiology has a significant number of near–term commercial opportunities, and the list of new products and applications is continuously growing. Applications include specialtychemicals, enzymes, synthetic genes and other DNA parts as well as pharmaceuticals, diagnostics, agricultural seeds, vaccines, biofuels, and chassis microorganisms.It is important for companies in industries impacted by synthetic biology to sort through the many potential applications; to identify near–term commercialopportunities for product development and competitive strategy. This report provides pertinent information to assist companies in prioritizing product opportunities, andestablishing a solid framework for strategic planning.Synthetic biology encompasses a range of industries including life science tools, biotechnology, pharmaceuticals, diagnostics, energy, and chemicals. Because of itswide scope, synthetic biology plays an important role in the future industrial economy. Continuing advances in enabling technologies such as DNA synthesis and sequencing,specialty media, and bioinformatics, as well as a need for renewable feedstocks, are driving the growth of the synthetic biology market. Developments in thesemultidisciplinary fields promise to advance the synthetic biology industry and create unique market opportunities. This report analyzes these trends and their impact on thefuture markets for synthetic biology products. Based on these market and technology dynamics, it is especially timely to examine the current and future synthetic biology markets.
CONTRIBUTION OF THE STUDY AND FOR WHOMWe have compiled a study of existing and future synthetic biology products and technologies that will be commercially important in the main end–user segments of lifescience research, pharmaceuticals, diagnostics, energy, chemicals, and agriculture. We present markets by end–user segment (R&D, diagnostics and pharmaceuticals,energy, chemicals, and agriculture) and by product type (enabling products, biologic components, integrated systems, and enabled products). Key market segments arecovered, including synthetic genes, agriculture, biofuels, specialty chemicals, and pharmaceuticals. We analyze synthetic biology technologies, growth driving forces, market applications, industry structure and competitive dynamics, companies and industry alliances, future market potential, and product sales forecasts for the period 2013 through 2018. We project the future use of synthetic biology products in the main end–user segments and by product type.This report will be of particular interest to companies in the industries of pharmaceuticals, chemicals, enzymes, energy, agriculture, diagnostics, bioinformatics, biotechnology, and nanobiotechnology, as well as suppliers of genomics tools, DNA synthesis and DNA sequencing products. It will also be of high interest to professionalswithin governments and regulatory agencies to understand the scope and pace of synthetic biology technologies as they reach the market.
SCOPE AND FORMATThe study scope includes core synthetic biology products (synthetic genes, other DNA parts, chassis organisms, synthetic cells), enabling technologies (DNA sequencing,oligonucleotides, specialty media, bioinformatics), and enabled technologies (biofuels, specialty chemicals, diagnostics, pharmaceuticals, agriculture) that are alreadycommercialized or are forecast to be commercialized within the next five years. We analyze key synthetic biology technologies and products to determine present andfuture market status, and forecasted growth from 2013 through 2018. We also discuss strategic alliances, industry structures, competitive dynamics, patents, and marketdriving forces.BCC Research examines the synthetic biology industry by market segment, including suppliers of synthetic genes, enzymes, pharmaceuticals, biofuels, and specialtychemicals. The role of key strategic alliances from 2012 through 2014 is discussed. Emerging markets including synthetic genes, synthetic biology–enabled drugs andvaccines, chassis organisms, as well as metabolically–engineered factories for producing synthetic fuels and specialty chemicals are analyzed and more than 130companies in these fields are highlighted.
METHODOLOGYBCC Research surveys key users and producers in each of the end–user market segments and technology fields that will be commercially important during the nextfive years. Discussions with industry thought leaders, as well as secondary market research was performed. Based on our analysis, we project the future applications of synthetic biology technologies in the major end–user market segments and by technology type, and forecast sales revenues for 2013 through 2018.
Download the full report: https://www.reportbuyer.com/product/2212006/
About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.com
For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
SOURCE ReportBuyer
